Granules India Ltd Gains 3.93%: 6 Key Factors Driving the Week’s Momentum

2 hours ago
share
Share Via
Granules India Ltd delivered a solid weekly gain of 3.93%, closing at Rs.833.15 on 3 July 2026, outperforming the Sensex’s 1.31% rise over the same period. The stock demonstrated strong resilience and momentum, hitting multiple 52-week and all-time highs amid robust financial results and positive technical signals, marking a notable week for investors in the Pharmaceuticals & Biotechnology sector.

Key Events This Week

29 Jun: New 52-week high (Rs.818.85) and all-time high (Rs.798.55)

1 Jul: New 52-week and all-time high at Rs.829.65

3 Jul: New 52-week high of Rs.840 and all-time high of Rs.834.35

3 Jul: Week closes at Rs.833.15 (+3.93%) outperforming Sensex (+1.31%)

Week Open
Rs.801.65
Week Close
Rs.833.15
+3.93%
Week High
Rs.840
vs Sensex
+2.62%

Monday, 29 June 2026: New 52-Week and All-Time Highs Spark Momentum

Granules India Ltd began the week on a strong note, hitting a new 52-week high of Rs.818.85 and an all-time high intraday price of Rs.798.55. The stock closed at Rs.813.05, up 1.42%, significantly outperforming the Sensex which declined marginally by 0.01%. This surge followed a reversal from a two-day decline, signalling renewed investor confidence. The company’s robust financials, including a quarterly net sales record of Rs.1,470.61 crore and a strong operating profit to interest ratio of 10.77 times, underpinned this strength. Institutional investors increased their holdings by 1.29%, further supporting the rally.

Tuesday, 30 June 2026: Slight Consolidation Amid Broader Market Gains

On 30 June, the stock experienced a minor pullback, closing at Rs.811.65, down 0.17%, while the Sensex gained 0.45%. Despite the slight dip, Granules India Ltd maintained its position above all key moving averages, reflecting sustained technical strength. The day’s subdued volume of 97,427 shares suggested profit-taking after Monday’s gains, but the overall trend remained intact.

Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!

  • - Expert-scrutinized selection
  • - Already delivering results
  • - Monthly focused approach

Get Next Month's Pick →

Wednesday, 1 July 2026: New 52-Week and All-Time High at Rs.829.65

Granules India Ltd resumed its upward trajectory on 1 July, reaching a fresh 52-week and all-time high of Rs.829.65. The stock closed at Rs.826.55, up 1.84%, outperforming the Sensex’s 0.71% gain. This marked the third consecutive day of gains, with a cumulative return of 7.13% over this period. The stock’s technical indicators, including bullish MACD and KST signals, reinforced the positive momentum. Institutional confidence remained strong, with holdings at 32.32%. The company’s financial health, highlighted by a ROCE of 16.82% and a low Debt to EBITDA ratio of 1.28 times, continued to support investor sentiment.

Thursday, 2 July 2026: Continued Gains Amid Sector Strength

On 2 July, Granules India Ltd extended its rally, closing at Rs.833.15, up 0.80%, while the Sensex rose 0.15%. The stock’s position above all major moving averages and positive technical signals sustained the bullish outlook. Delivery volumes showed a healthy increase, indicating strong participation from long-term holders and institutional investors. The Pharmaceuticals & Biotechnology sector also exhibited strength, contributing to the favourable environment for the stock.

Want to dive deeper on Granules India Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Friday, 3 July 2026: New 52-Week High of Rs.840 and All-Time High of Rs.834.35

Granules India Ltd capped the week by hitting a new 52-week high of Rs.840 and an all-time high of Rs.834.35 on 3 July. The stock closed at Rs.833.15, up 0.80% on the day, outperforming the Sensex’s 0.59% gain. Intraday volatility was elevated at 14.8%, reflecting active trading interest. The stock’s technical indicators remained predominantly bullish, supported by strong institutional holdings and solid financial metrics. The company’s net sales and operating profit margins remain robust, with cash reserves at an all-time high of Rs.949.06 crore, underscoring liquidity strength. Despite a premium valuation, the stock trades at a discount relative to sector peers’ historical averages, balancing growth prospects with valuation considerations.

Date Stock Price Day Change Sensex Day Change
2026-06-29 Rs.801.65 +— 35,960.98 +—
2026-06-30 Rs.813.05 +1.42% 35,958.71 -0.01%
2026-07-01 Rs.811.65 -0.17% 36,119.01 +0.45%
2026-07-02 Rs.826.55 +1.84% 36,376.02 +0.71%
2026-07-03 Rs.833.15 +0.80% 36,431.45 +0.15%

Key Takeaways

Strong Price Momentum: Granules India Ltd outperformed the Sensex by 2.62% over the week, driven by multiple new 52-week and all-time highs, reflecting robust investor demand and confidence.

Robust Financials: The company’s record quarterly net sales of Rs.1,470.61 crore, high operating profit to interest ratio of 10.77 times, and substantial cash reserves of Rs.949.06 crore underpin its strong fundamentals.

Institutional Support: Institutional investors hold a significant 32.32% stake, having increased their holdings by 1.29% over the previous quarter, signalling sustained confidence in the company’s growth prospects.

Technical Strength: Bullish signals from MACD, KST, Bollinger Bands, and sustained trading above all key moving averages confirm the stock’s positive technical outlook.

Valuation Considerations: Despite premium valuation multiples (P/E ~34x, PEG ~1.4), the stock trades at a discount relative to sector peers’ historical averages, balancing growth with valuation.

Sector Tailwinds: The Pharmaceuticals & Biotechnology sector’s positive momentum, with multiple indices hitting new highs, complements Granules India Ltd’s individual performance.

Conclusion

Granules India Ltd’s performance over the week ending 3 July 2026 highlights a compelling combination of strong financial results, technical momentum, and institutional backing. The stock’s consistent outperformance relative to the Sensex and sector peers underscores its resilience and operational strength within the Pharmaceuticals & Biotechnology sector. While valuation metrics suggest a premium, the company’s robust fundamentals and positive market sentiment provide a solid foundation for its current market standing. Investors should continue to monitor the balance between growth prospects and valuation as the stock sets new benchmarks in its trading history.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News